Document Details

Document Details

Filing Type

8-K (SEC's EDGAR System)

Company Diffusion Pharmaceuticals Inc. (Charlottesville, VA)
Event Date 9/21/2018
Filing Date 9/27/2018

Abstract: 8-K filed by Diffusion Pharmaceuticals Inc. (DFFN) covering Entry into a Material Definitive Agreement; Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers; and Financial Statements and Exhibits.
Download

File Section(s)

  1. FORM 8-K
  2. EXHIBIT 10.1
  3. EXHIBIT 10.2

Note: This document was filed with the SEC in HTML format, as allowed by the recent EDGAR system modernization. S&P cannot take responsibility for its appearance, layout, or legibility.